A 2026 UK evidence review of the synaptic plasticity hypothesis, BDNF, fear extinction & SSRI alternatives
And yes, we root for sellout
The growing interest in these natural extracts and compounds is driven by their potential as complementary or alternative therapies in managing diseases linked to oxidative stress
Adipokines: New potential therapeutic target for obesity and metabolic, rheumatic, and cardiovascular diseases
Introduction Cardiovascular disease (CVD) is the main cause of morbidity and mortality in patients with type 2 diabetes (T2DM), with a relevant impact on the economic costs for health care systems and on the quality of life for many patients ( Among the novel therapies, great interest has been aroused by sodiumglucose cotransporter-2 inhibitors (SGLT2-i) and glucagon-like peptide-1 receptor agonist (GLP1-RA), that have changed the management of diabetic patients
doi: 10.1155/2019/4578462 48